Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study. Issue 7 (July 2020)

• Record Type: Journal Article
• Authors: Roberts, Teryn R.; Harea, George T.; Singha, Priyadarshini; Sieck, Kyle N.; Beely, Brendan M.; Wendorff, Daniel S.; Choi, Jae Hyek; Ande, Sreedevi; Handa, Hitesh; Batchinsky, Andriy I.
• Is Part Of: ASAIO journal. Volume 66:Issue 7(2020)
• Publication Date: 2020-07
• Subjects: extracorporeal life support -- blood coagulation -- biocompatible materials -- thrombosis -- fluorocarbons -- respiratory therapy; Artificial organs -- Periodicals; 617
• DOI: 10.1097/MAT.0000000000001055
• Languages: English
• ISSNs: 1058-2916

Abstract

Abstract : Coagulation management is the leading challenge during extracorporeal life support (ECLS) due to shear stress and foreign-surface–induced coagulation disturbance during circulation. A nonadhesive, liquid-infused coating called tethered liquid perfluorocarbon (TLP) was developed to prevent adhesion of blood on medical materials. We investigated the novel application of TLP to commercial ECLS circuits compared with standard heparin-coated circuits in vivo in anesthetized swine for 6 hours veno-venous ECLS (1 L/min blood flow) without systemic anticoagulation (n = 3/group). We hypothesized that TLP coating permits heparin-free circulation without untoward effects while reducing thrombus deposition compared with controls. Vital signs, respiration, gas transfer, coagulation, and histology were assessed. Scanning electron microscopy (SEM), elemental mapping, and digital imaging were used to assess thrombus deposition after circulation. There were no group differences in vitals, gas exchange, coagulation, and histology. In both groups, ECLS enabled a decrease in minute volume and end-tidal CO2, with concomitant increase in pH ( p < 0.05). Scanning electron microscopy and digital imaging revealed significant thrombus on heparin-coated membranes, which was reduced or absent on TLP-coated materials. Tethered liquid perfluorocarbon permitted heparin-free ECLS without altering device performance and prevented thrombus deposition versus immobilized heparin. Pending multiday in vivo testing, TLP is a promising biomaterial solution to eliminate anticoagulation requirements during ECLS. Abstract : Supplemental Digital Content is available in the text.